drugset / Trial / NCT03603964
Guadecitabine Extension Study
NaSingle-groupOpen-labelTreatment
Summary
This is a multicenter, open-label extension study for participants who participated in a previous Astex-sponsored guadecitabine clinical study \[including but not limited to SGI-110-01 (NCT01261312), SGI-110-04 (NCT02348489), SGI-110-06 (NCT02920008), and SGI-110-07 (NCT02907359)\].
Timeline
- Start
- 2018-07-18
- Primary completion
- 2021-10-04
- Completion
- 2021-10-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Guadecitabine | Oligonucleotide (other) | — | Subcutaneous |